TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier
Authors
Keywords
CCL-2, hCMEC/D3, HMEC, IL-8, MMP-9, Neuroinflammation, TNFSF12, ZO-1
Journal
Journal of Neuroinflammation
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-01-16
DOI
10.1186/1742-2094-10-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of TWEAK in lupus nephritis: A bench-to-bedside review
- (2012) Jennifer S. Michaelson et al. JOURNAL OF AUTOIMMUNITY
- The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases; focus on inflammatory bowel diseases
- (2012) Taeko Dohi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system
- (2012) Ramiro Echeverry et al. Journal of Neuroinflammation
- Suppression of MMP-9 Expression in Brain Microvascular Endothelial Cells (BMVEC) Using a Gold Nanorod (GNR)-siRNA Nanoplex
- (2011) Supriya D. Mahajan et al. IMMUNOLOGICAL INVESTIGATIONS
- TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses
- (2011) Linda C. Burkly et al. IMMUNOLOGICAL REVIEWS
- Truncation of monocyte chemoattractant protein 1 by plasmin promotes blood-brain barrier disruption
- (2011) Y. Yao et al. JOURNAL OF CELL SCIENCE
- TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade
- (2009) A W R van Kuijk et al. ANNALS OF THE RHEUMATIC DISEASES
- Soluble TWEAK Plasma Levels as a Novel Biomarker of Endothelial Function in Patients with Chronic Kidney Disease
- (2009) M. I. Yilmaz et al. Clinical Journal of the American Society of Nephrology
- TNF-Like Weak Inducer of Apoptosis (TWEAK) Activates Proinflammatory Signaling Pathways and Gene Expression through the Activation of TGF- -Activated Kinase 1
- (2009) M. Kumar et al. JOURNAL OF IMMUNOLOGY
- Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain
- (2009) Wanqiu Chen et al. JOURNAL OF NEUROCHEMISTRY
- A New Role for TIMP-1 in Modulating Neurite Outgrowth and Morphology of Cortical Neurons
- (2009) Adlane Ould-yahoui et al. PLoS One
- Tumor Necrosis Factor-related Weak Inducer of Apoptosis Augments Matrix Metalloproteinase 9 (MMP-9) Production in Skeletal Muscle through the Activation of Nuclear Factor-κB-inducing Kinase and p38 Mitogen-activated Protein Kinase
- (2008) Hong Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TWEAK is expressed at the cell surface of monocytes during multiple sclerosis
- (2008) S. Desplat-Jego et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Expression of TWEAK and Its Receptor Fn14 in the Multiple Sclerosis Brain: Implications for Inflammatory Tissue Injury
- (2008) Barbara Serafini et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Immune cell entry into the central nervous system: Involvement of adhesion molecules and chemokines
- (2008) Britta Engelhardt JOURNAL OF THE NEUROLOGICAL SCIENCES
- Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells
- (2008) Oualid Sbai et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
- (2008) Jeffrey A. Winkles NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now